Managing the Neuropsychiatric Manifestations of Parkinson's Disease (PD): An Update for Pharmacists and Nurses
Psychiatric-mental health nurses serve on the front line of care and are uniquely positioned to play an essential role in the assessment of neuropsychiatric manifestations of PD, their treatment and management, and the delivery of supportive care to both patients and caregivers. Through interactive case-based presentations and expert discussion, this activity will review current and novel therapies for neuropsychiatric symptoms of patients with PD as well as strategies to manage their adverse events and DDIs.
Presenters: Jack J. Chen, PharmD, FASCP, FCCP, BCPS, BCGP and Dawn M. Vanderhoef, PhD, DNP, PMHNP-BC, FAANP
Target Audience: RN, APRN
Upon the conclusion of this activity, learners will be able to:
1. Recognize the prevalence of neuropsychiatric symptoms in PD and their impact on disease burden.
2. Evaluate current and novel treatment options for the various neuropsychiatric symptoms.
3. Discuss the role of psychiatric nurses and pharmacists in managing the neuropsychiatric symptoms of PD.
4. Assess strategies to minimize the impact adverse events and DDIs have on patient outcomes.
Continuing Education Credit:
1.5 contact hours. *In order to receive contact hours for the program, participants must: View the program in its entirety, earn a passing score of at least 80% on the post-test, and complete the final evaluation. Participants will have 5 opportunities to correctly answer the questions on the post-tests. Following completion of the presentation, post-test and evaluation the certificate will be generated online, available for immediate printing. Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation of the continuing education activity does not imply endorsement by APNA or ANCC of any commercial products discussed in the context of this activity.
The Nurse Planner and members of the planning committee have no financial relationships to disclose.
Dr. Chen reports serving on the speaker’s bureau for ACADIA Pharmaceuticals Inc.
Dr. Vanderhoef reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Support for the Program:
This program is supported through an educational grant from Acadia Pharmaceuticals.
Release Date: April 17, 2017
The contact hours for this session expire: April 15, 2019.